|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|3234840||1205430||2015||5 صفحه PDF||ندارد||دانلود کنید|
BackgroundRobotic assisted radical prostatectomy (RARP) has become the commonest minimally invasive surgical procedure for the treatment of localized prostate cancer. Despite limited data supporting the excellence of RARP over laparoscopic radical prostatectomy (LRP) or open radical prostatectomy (ORP), it has gained wide acceptance among the patients and surgeons.ObjectivesThe aim of this review is to present the most recent data and analyze the current status of RARP.MethodsMedline was searched from 2005 to March 2015, restricted to English language. The Medline search used a strategy including medical subject headings (MeSH) and free-text protocols.ResultsRARP is equivalent to ORP in cancer control and may be advantageous in the preservation of continence and potency.ConclusionsAvailable data suggest that RARP is a valuable therapeutic option for localized prostate cancer.
Journal: Apollo Medicine - Volume 12, Issue 2, June 2015, Pages 82–86